Stay updated on Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial page.

Latest updates to the Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the record history. The notices about government funding and updates to the earlier Revision: v3.4.1 entry were removed.SummaryDifference0.9%

- Check21 days agoChange DetectedA new version 3.4.1 was added to the record history, and a site-wide funding notice about government operating status was displayed, replacing the previous version 3.4.0.SummaryDifference0.9%

- Check28 days agoChange DetectedUI updates include a glossary toggle and color-coded change highlights, plus an updated Revision: v3.4.0 that replaces the previous v3.3.4. Additionally, the No FEAR Act data text was updated.SummaryDifference1%

- Check35 days agoChange DetectedA new revision entry v3.3.4 was added to the history, while the previous revision v3.3.3 was removed.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.3 was added. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check85 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.3.1 from the Study Record Versions.SummaryDifference0.1%

Stay in the know with updates to Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial page.